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Abstract: A large number of diseases may cause Atrophic skin disorders are caused by a large number of dis-
eases, some of them idiopathic and others inflammatory, in which there is loss of volume of body segments.
Localized scleroderma is a rare inflammatory dermatosis, manifested by atrophic skin and subcutaneous tissue
alterations. Lipoatrophy may be genetically inherited or acquired as a result of panniculitis, HIV infections or
aging. Many treatments have been proposed. Results vary in the acute inflammatory phase and are scarce when
sclerosis and atrophy have already been established. This article describes four cases of localized facial scleroder-
ma and one of facial idiopathic lipoatrophy treated with implantation of autologous fat globules extracted from
the infragluteal groove, without utilization of cannula aspiration, with lasting results.
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Resumo: Os distúrbios atróficos da pele abrangem inúmeras doenças, algumas idiopáticas e outras, inflamató-
rias, em que há perda do volume de segmentos do corpo. A esclerodermia localizada é uma dermatose inflama-
tória, rara, que pode manifestar-se com alterações atróficas da pele e tecido subcutâneo. A lipoatrofia pode ser
herdada geneticamente ou adquirida relacionada a paniculites, infeccção pelo HIV, ou envelhecimento. Muitos
tratamentos são propostos. Os resultados são variáveis na fase inflamatória aguda e apresentam pouca resposta
quando a esclerose e atrofia já estão instaladas. Descreve-se o tratamento de quatro casos de esclerodermia loca-
lizada e um de lipoatrofia idiopática, na face, tratados com enxerto de fragmentos de lóbulos de gordura autólo-
ga extraídos sem a utilização da cânula aspirativa, com resultados duradouros.
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INTRODUCTION
A large number of diseases are related to
atrophic and sclerodermal skin disturbances, and can
be either genetic or acquired. Scleroderma is a chronic
spectral disease which is defined by a series of skin
alterations. In localized form it is known as morphea,
which can affect adjacent muscles and bones. Its etiol-
ogy is not completely understood and it is estimated
that 50% of cases go into remission within 2.7 years of
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the onset of the disease.1 Following the initial inflam-
matory reaction, there is a localized progressive
involvement of fibrosis, atrophy with hypo or hyper-
pigmentation. This disease is rare, and occurs pre-
dominantly in young adults.2 Lesions can be disfigur-
ing, and can manifest themselves in linear forms and
affect all of a hemiface with the Parry Romberg syn-
drome, described in 1846.3
CASE REPORT
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Several treatments have been proposed with
varying results, taking into consideration the stage of
the illness, age of the patient, and localization and
extension of the lesions. Therapeutic options include
corticosteroids, methotrexate, calcipotriol, imiqui-
mod, tacrolimus, ultraviolet A and CO2 fractional
laser treatment.1,2,4,5
Facial lipoatrophy can be genetically inherited,
without specific related pathology, or can be associat-
ed with a variety of conditions, including panniculitis,
HIV infection, or aging.
6
There are many surgical reconstructive tech-
niques used where loss of volume to the face or other
areas has occurred. Synthetic filling materials such as
hyaluronic acid, calcium hydroxyapatite, and poly-l-
lactic-acid can be used.7,8 In addition, there are reports
of the use of autologous fat globules, demineralized
bone matrix, and flaps.9,10
This study presents patients treated with the
implantation of autologous fat globules with septa of
connective tissue, extracted without cannula aspira-
tion, and producing long-term results.
CASE REPORT
The authors report one case of facial idiopathic
lipoatrophy in a male patient and four cases of sclero-
derma in two males and two female patients from 17
to 26 years of age, all presenting linear lesions and
atrophy on the face, without inflammation and stable
in their dimensions (Figure 1). The cases of facial scle-
roderma correspond clinically to Romberg syndrome.
The patients were admitted to the medical facili-
ty on the day of the surgery and released the same day.
The infragluteal fold was chosen as the donor
site. Following sterilization with ipovidone iodine
scrub (PVP-I), the patients were anesthetized with 2%
lidocaine applied to one infragluteal fold per session.
An incision of approximately 5 cm was made in the
skin, dissected to the subcutaneous tissue from which
the fragments of fat were taken with the use of
anatomical forceps and iris scissors. Internal and
external sutures were used to close the incision, using
4-0 nylon thread. The fragments were processed in
small dimensions of approximately 0.3 cm, and stored
in a refrigerated saline solution (Figure 2).
Preparations were begun at the receiving site
with localized scleroderma. Anesthetic infiltration
with 1% lidocaine or locoregional anesthetic block
was injected, for example in the malar region. A small
incision of approximately 0.5 cm was made, prefer-
ably on the margin of the lesion. Through this small
opening, the sclerotic area was carefully peeled from a
deep level, using scissors and a grooved probe, creat-
ing a space beneath the sclerodermal lesion (Figure 3).
A 60 ml urological syringe was used to decant
the material and introduce the receptor into the space,
under light pressure (Figure 2). After filling the space
to the point of improving the appearance of atrophy,
the small incision was sutured and the necessary
bandages applied to the region (Figure 4). Antibiotic
therapy was prescribed for 7 days. Ablation occurred
from 7-10 days in the receptor region and 14 days at
the donor site (Figure 5).
FIGURE 1: Cases of scleroderma lesions and atrophy on the face
DISCUSSION
Autologous fat transplants are utilized in a
series of conditions in which there is loss of local vol-
ume. The materials available for correction of scleroa-
trophy have become restricted because there is always
the possibility that their composition or molecular
fragments will cause adverse reactions and worsen
the disease.6
Corrections of localized scleroderma and idio-
pathic lipodystrophy are important to patients
because these diseases can manifest in a disfiguring
form. Among the modalities of treatment, there are
techniques for implantation of small fragments of fat.
These are processed in a practical manner with a
scalpel blade, which eliminates other types of
recourse.
Some studies indicate that 45% of the volume of
fatty tissue inserted can be absorbed after one year, fol-
lowing conventional implants obtained by aspiration.10
In scleroderma, inserts seem to last longer, as has been
observed in cases relating to follow-up longer than one
year (Figure 6). It is possible to suppose that implants
obtained of fat fragments with septa of connective tis-
sue will permit better surface contact with the receiv-
ing tissues, better nutrition and adaptation to the
receptor layer. Treatment of the frontal region tends to
be longer lasting than the chin region and infra orbital
region. 10 This could be explained by the detachment of
the entire region which creates adequate layers for
receiving the fragments.
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Contraindications for this procedure include
coagulation disturbances, acute infections, chronic ill-
ness and alterations of lipid metabolism. The most
common complications are ecchymoses, edemas, fat






Immediate results can be seen in post surgery,
although it might be necessary to repeat the procedure
to obtain the desired results.
None of the patients experienced major
hematomas in the receptacle or donor regions.
It can be concluded that the technique
described is a good therapeutic option in cases of
localized lipodystrophy and especially facial sclero-
derma. In this region, there is low density in the sub-
cutaneous tissue and major bone support.
The fat fragments with septa of connective tis-
sue, extracted without the use of cannula and aligned
to the detachment in the receptive region can produce
lasting results, without the utilization of sophisticated
recourses or the utilization of fillers which could reac-
tivate the disease. q
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